|
|
Lupin is among the leading pharmaceutical companies with core focus on the brand building and market place. It's focused on New Drug Delivery Systems (NDDS) and niche opportunities so as to provide superior compliance. Lupin Ltd. was founded on 31st March 1983 as a private ltd. company.
Its product portfolio includes anti-tuberculosis, cephalosporins, anti-asthma, cardiovascular, and non-steroid anti-inflammatory drugs. Lupin has 9 USFDA- approved manufacturing facilities. The Lupin research park (India) has about 160 scientists. Currently, the company is setting up a project for the manufacturing of 93 Tissue Plasminogen Activators (TPA) of Rifampicin, which is an essential anti-tuberculosis, anti-leprotic, life saving drug from a very basic stage of fermentation.
|